BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors. 2021

Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, İzmir, Turkey.

A series of novel 4-aminobenzensulfonamide/carboxamide derivatives bearing naphthoquinone pharmacophore were designed, sythesized and evaluated for their proteasome inhibitory and antiproliferative activities against human breast cancer cell line (MCF-7). The structures of the synthesized compounds were confirmed by spectral and elemental analyses. The proteasome inhibitory activity studies were carried out using cell-based assay. The antiproteasomal activity results revealed that most of the compounds exhibited inhibitory activity with different percentages against the caspase-like (C-L, β1 subunit), trypsin-like (T-L, β2 subunit) and chymotrypsin-like (ChT-L, β5 subunit) activities of proteasome. Among the tested compounds, compound 14 bearing 5-chloro-2-pyridyl ring on the nitrogen atom of sulfonamide group is the most active compound in the series and displayed higher inhibition with IC50 values of 9.90 ± 0.61, 44.83 ± 4.23 and 22.27 ± 0.15 μM against ChT-L, C-L and T-L activities of proteasome compared to the lead compound PI-083 (IC50 = 12.47 ± 0.21, 53.12 ± 2.56 and 26.37 ± 0.5 μM), respectively. The antiproliferative activity was also determined by MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay in vitro. According to the antiproliferative activity results, all of the compounds exhibited cell growth inhibitory activity in a range of IC50 = 1.72 ± 0.14-20.8 ± 0.5 μM and compounds 13 and 28 were found to be the most active compounds with IC50 values of 1.79 ± 0.21 and 1.72 ± 0.14 μM, respectively. Furthermore, molecular modeling studies were carried out for the compounds 13, 14 and 28 to investigate the ligand-enzyme binding interactions.

UI MeSH Term Description Entries
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001555 Benzene Derivatives Organic compounds derived from BENZENE. Derivatives, Benzene
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D061986 MCF-7 Cells An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.) MCF7 Cells,Michigan Cancer Foundation 7 Cells,Cell, MCF-7,Cell, MCF7,Cells, MCF-7,Cells, MCF7,MCF 7 Cells,MCF-7 Cell,MCF7 Cell
D061988 Proteasome Inhibitors Compounds that inhibit the function or proteolytic action of the PROTEASOME. Proteasome Endopeptidase Complex Inhibitors,Proteasome Inhibitor,Inhibitor, Proteasome,Inhibitors, Proteasome
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
September 2018, European journal of medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors.
January 2014, European journal of medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors.
August 2016, Bioorganic & medicinal chemistry letters,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors.
August 2010, Bioorganic & medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors.
January 2019, European journal of medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
March 2017, European journal of medicinal chemistry,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
July 2018, Bioorganic & medicinal chemistry letters,
Sirin Uysal, and Zeynep Soyer, and Merve Saylam, and Ayse H Tarikogullari, and Sinem Yilmaz, and Petek Ballar Kirmizibayrak
Design, synthesis and biological evaluation of novel diazaspirodecanone derivatives containing piperidine-4-carboxamide as chitin synthase inhibitors and antifungal agents.
September 2021, Bioorganic chemistry,
Copied contents to your clipboard!